Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010403
Filing Date
2019-11-07
Accepted
2019-11-07 16:32:23
Documents
77
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20190930x10q.htm 10-Q 1812048
2 EX-10.4 ampe-20190930ex104d90a64.htm EX-10.4 20356
3 EX-31.1 ampe-20190930ex311c965dd.htm EX-31.1 18900
4 EX-31.2 ampe-20190930ex312c72e8b.htm EX-31.2 18762
5 EX-32.1 ampe-20190930ex321c44a71.htm EX-32.1 10090
6 GRAPHIC ampe20190930x10q001.jpg GRAPHIC 4975
  Complete submission text file 0001558370-19-010403.txt   7615809

Data Files

Seq Description Document Type Size
7 EX-101.INS ampe-20190930.xml EX-101.INS 1833965
8 EX-101.SCH ampe-20190930.xsd EX-101.SCH 54778
9 EX-101.CAL ampe-20190930_cal.xml EX-101.CAL 39196
10 EX-101.DEF ampe-20190930_def.xml EX-101.DEF 185376
11 EX-101.LAB ampe-20190930_lab.xml EX-101.LAB 386525
12 EX-101.PRE ampe-20190930_pre.xml EX-101.PRE 357764
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 191200846
SIC: 2834 Pharmaceutical Preparations